Home

THOMAS I H DUBIN

CIK 1231945 · SVP & Chief Legal Officer · last filed 2026-07-20

THOMAS I H DUBIN is a SVP & Chief Legal Officer who has filed 54 SEC Form 4 insider transactions across 2 companies since 2024. The most recent filing, for INTS, was dated Jul 20, 2026. 59 SEC filings were submitted jointly with ALEXION PHARMACEUTICALS, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

54

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
C/O ALEXION PHARMACEUTICALS INC
352 KNOTTER DRIVE
CHESHIRE, CT 06410
Related Filers
ALEXION PHARMACEUTICALS, INC. — 59 joint filings, latest 2012-08-27
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INTS Director — $3.80 — $0 3 2026-07-20
Notable Labs, Ltd. (NTBL) Delisted Director 40,247 $0.25 $10.0K $0 2 2024-05-10

Recent Filings

54 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-20 INTS Grant (A) — $0 EDGAR
2025-05-06 INTS Grant (A) — $0 EDGAR
2024-05-15 INTS Grant (A) — $0 EDGAR
2024-05-10 Notable Labs, Ltd. (NTBL) Delisted Grant (A) +40,247 $0 EDGAR
2024-01-26 Notable Labs, Ltd. (NTBL) Delisted Grant (A) — $0 EDGAR
2012-08-27 — Sell (S) −33,528 -$3.46M
2012-07-31 — Mixed −1,348 -$14.34M
2012-06-19 — Mixed — -$3.25M
2012-05-31 — Mixed — -$8.09M
2012-05-14 — Exer (M) +38,688 $406.0K
Showing 1–10 of 54
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.